Company intelligence / Profile preview

Blood Disorders Center

Ownership: Private
Development stage: Other

Overview

The Blood Disorders Center is a specialized healthcare provider focused on the diagnosis, treatment, and management of a wide range of hematologic conditions. The center provides comprehensive care for both benign and malignant blood disorders, including sickle cell disease, hemophilia, and various blood cancers. By integrating clinical expertise with access to advanced therapies and clinical trials, the center serves as a critical hub for patients requiring specialized hematological intervention. Its services encompass diagnostic testing, infusion therapy, and long-term disease management.

Therapeutic areas: HematologyCardiovascularOncology
Modalities: Small moleculeMonoclonal antibodyBiologicCell therapy
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on Blood Disorders Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood Disorders Center.

Explore the full profile